Community Health Systems, Inc. (CYH)
NYSE: CYH · IEX Real-Time Price · USD
-0.185 (-5.82%)
Jun 25, 2024, 1:25 PM EDT - Market open

Community Health Systems Revenue

Community Health Systems had revenue of $12.52B in the twelve months ending March 31, 2024, with 2.57% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $3.14B with 1.03% year-over-year growth. In the year 2023, Community Health Systems had annual revenue of $12.49B with 2.28% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
416.20M USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 202312.49B279.00M2.28%
Dec 31, 202212.21B-157.00M-1.27%
Dec 31, 202112.37B579.00M4.91%
Dec 31, 202011.79B-1.42B-10.76%
Dec 31, 201913.21B-945.00M-6.68%
Dec 31, 201814.16B-1.20B-7.80%
Dec 31, 201715.35B-3.09B-16.73%
Dec 31, 201618.44B-999.00M-5.14%
Dec 31, 201519.44B798.00M4.28%
Dec 31, 201418.64B5.82B45.40%
Dec 31, 201312.82B-14.00M-0.11%
Dec 31, 201212.83B926.79M7.78%
Dec 31, 201111.91B813.79M7.34%
Dec 31, 201011.09B-650.03M-5.54%
Dec 31, 200911.74B823.36M7.54%
Dec 31, 200810.92B3.82B53.88%
Dec 31, 20077.10B2.92B69.75%
Dec 31, 20064.18B604.02M16.89%
Dec 31, 20053.58B372.61M11.63%
Dec 31, 20043.20B526.99M19.69%
Dec 31, 20032.68B513.14M23.72%
Dec 31, 20022.16B469.76M27.74%
Dec 31, 20011.69B356.12M26.63%
Dec 31, 20001.34B257.55M23.85%
Dec 31, 19991.08B225.37M26.37%
Dec 31, 1998854.58M112.23M15.12%
Dec 31, 1997742.35M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Enhabit 1.04B
Voyager Therapeutics 119.04M
Alector 96.41M
Theravance Biopharma 61.51M
EyePoint Pharmaceuticals 50.02M
MaxCyte 44.05M
Fate Therapeutics 6.48M
IGM Biosciences 2.11M
Revenue Rankings